tiprankstipranks
Blurbs

Analysts Offer Insights on NA Companies: Invivyd (IVVD) and iSun (ISUN)

There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on Invivyd (IVVDResearch Report) and iSun (ISUNResearch Report) with bullish sentiments.

Invivyd (IVVD)

In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Invivyd, with a price target of $5.00. The company’s shares closed last Thursday at $1.06, close to its 52-week low of $1.03.

According to TipRanks.com, Trucchio has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -18.5% and a 30.5% success rate. Trucchio covers the Healthcare sector, focusing on stocks such as Freeline Therapeutics Holdings, Milestone Pharmaceuticals, and Arrowhead Pharmaceuticals.

Invivyd has an analyst consensus of Hold, with a price target consensus of $3.00.

See the top stocks recommended by analysts >>

iSun (ISUN)

H.C. Wainwright analyst Amit Dayal initiated coverage with a Buy rating on iSun today and set a price target of $2.75. The company’s shares closed last Thursday at $0.54, close to its 52-week low of $0.47.

According to TipRanks.com, Dayal is a top 100 analyst with an average return of 35.2% and a 39.5% success rate. Dayal covers the NA sector, focusing on stocks such as Calumet Specialty Products, Westport Fuel Systems, and Ballard Power Systems.

iSun has an analyst consensus of Strong Buy, with a price target consensus of $2.42.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on IVVD:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles